Nuevolution - Clinical development in 2019
Nuevolution’s drug discovery platform (Chemetics) continues to receive external validation, with Amgen opting in for another oncology programme...
50 Views
Nuevolution - Pipeline and partnerships continue to strengthen
With the completion of the up-listing to the Nasdaq Stockholm main market and the successful gross SEK110m capital raise, Nuevolution continues to...
67 Views
Nuevolution - Pipeline and strategic execution drives prospects
Nuevolution’s 2017 was defined by internal progress of the RORγt inhibitor and BET-BD1 programmes (expected to be clinically ready in 2019). In...
55 Views
Nuevolution - On the road to becoming a clinical company
July to September 2017 results highlight the continued progression of Nuevolution into a clinical company. Ongoing partnerships with Almirall,...
48 Views
Defining year as partnerships progress on track
FY17 has been a defining year for Nuevolution as it looks to further validate its unique Chemetics drug discovery platform. Highlights include the...
54 Views
No more insights